categorii
- Allergy / Immunology
- Anaesthesiology
- Anatomy
- Behavioural Medicine
- Biochemistry
- Cardiology
- Clinical Medicine
- Critical Care
- Dentistry
- Dermatology
- Embryology
- Emergency Medicine
- Endocrinology
- Epidemiology
- Evidence-Based Medicine
- Gastroenterology
- Genetics
- Geriatrics
- Haematology
- Health Professions
- Histology
- Infectious & Contagious Diseases
- Medicine: general issues
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Obstetrics / Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Otorhinolaryngology (ENT)
- Paediatrics
- Pathology
- Pharmacology
- Physiology
- Plastic Surgery
- Primary Care / General Practice
- Psychiatry
- Pulmonary & Respiratory Medicine
- Radiology / Imaging
- Rehabilitation Medicine
- Rheumatology
- Sleep Medicine
- Surgery
- Urology
- Veterinary Medicine
Home » Haematology » Chronic Myelogenous Leukemia, An Issue of Hematology/Oncology Clinics of North America
Chronic Myelogenous Leukemia, An Issue of Hematology/Oncology Clinics of North America
|
|
||||||||
- Seria:
- Categoria:
- Haematology
- Editia:
- Anul publicarii:
- 02.02.2012
- ISBN:
- 9781437725308
- Editura:
- Saunders
- Tip coperta:
- Hardback
- Format:
- Nr. pagini:
- Nr. ilustratii:
- Audienta:
Descriere:
Dr. Talpaz has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest include Selection of Therapy: Rational Decisions Based on Molecular Events; Is There a Potential Cure for CML in Current Therapies?; Hurdles Toward a Cure for CML: The CML Stem Cell; The CML Stem Cell in the Chronic and Advanced Disease; CML Disease Progression; Management of Ph+ ALL and CML Blast Crisis; BMT in CML in the Era of Targeted Therapy; Pharmacoeconomics: The Cost of Staying Alive; and The Significance of CML Prognostic Factors in the Era of Targeted Therapy.
Dr. Talpaz has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest include Selection of Therapy: Rational Decisions Based on Molecular Events; Is There a Potential Cure for CML in Current Therapies?; Hurdles Toward a Cure for CML: The CML Stem Cell; The CML Stem Cell in the Chronic and Advanced Disease; CML Disease Progression; Management of Ph+ ALL and CML Blast Crisis; BMT in CML in the Era of Targeted Therapy; Pharmacoeconomics: The Cost of Staying Alive; and The Significance of CML Prognostic Factors in the Era of Targeted Therapy.
Recomandata pentru:
06
06